C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 5,177 | 15,362 | 12,006 | 3,039 | 3,261 |
| Gross Profit | 5,177 | 15,362 | 12,006 | 3,039 | 3,261 |
| Operating Expenses | 42,886 | 43,606 | 33,448 | 35,258 | 40,688 |
| Operating Income | -37,709 | -28,244 | -21,442 | -32,219 | -37,427 |
| Interest Expense | -6,845 | 0 | -3,726 | -3,858 | 0 |
| Other Income | -3,578 | 3,578 | 0 | 0 | 2,950 |
| Pre-tax Income | -34,442 | -24,666 | -17,716 | -28,361 | -34,477 |
| Income Tax | N/A | N/A | N/A | N/A | 277 |
| Net Income Continuous | -34,573 | -24,666 | -17,716 | -28,361 | -34,754 |
| Net Income | $-34,573 | $-24,666 | $-17,716 | $-28,361 | $-34,754 |
| EPS Basic Total Ops | -0.50 | -0.35 | -0.26 | -0.41 | -0.68 |
| EPS Basic Continuous Ops | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 |
| EPS Diluted Total Ops | -0.50 | -0.35 | -0.26 | -0.41 | -0.68 |
| EPS Diluted Continuous Ops | -0.49 | -0.35 | -0.26 | -0.41 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.35 | -0.26 | N/A | N/A |
| EBITDA(a) | $-38,310 | $-29,187 | $-22,659 | $-33,036 | $-37,964 |